Curcumin (CUR), a derivative of turmeric, exhibits anti‐cancer properties in CRC, primarily through Nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) inhibition.14, 15. The gene discussed is NFKB1; the disease is cancer.